Request for Covid-19 Impact Assessment of this Report

Take Action
Pharmaceuticals

Global Atopic Dermatitis Treatment Market Size study, by Product (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Biologic Therapy, PDE-4 Inhibitor, Antibiotics, Antihistamines, Emollients) by Indication (Topical, Oral, Injectable) by end use industries (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores, Mail Order Pharmacies, Dermatology Clinics) and Regional Forecasts 2022-2028

  • BIZ4952909
  • 200 Pages
  • April 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
Global Atopic Dermatitis Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Atopic dermatitis (AD) is chronic inflammatory skin condition that usually affects the face (cheeks), neck, arms, and legs. It also usually spreads to the groin areas. Atopic dermatitis (AD) is common worldwide. People of all ages from newborns to adults 65 years of age and older live with this condition. Growing prevalence of dermatological skin disorders and rising Research & Development activities in healthcare industry are key drivers for the growth of Atopic Dermatitis Treatment market. For instance, according to National Eczema Association (NEA)- as of 2020 around 31.6 million people (10.1%) in the U.S. are suffering from some type of eczema. And approximately 9.6 million U.S. children under the age of 18 have AD, and one-third have moderate to severe disease. Furthermore, on January 5th , 2022, Swiss pharmaceutical company specializing in dermatological treatments and skin care products Galderma has acquired ALASTIN Skincare, Inc., a California based pharmaceuticals company and on January 14th , 2022, American biopharmaceutical company AbbVie has got approval from the U.S. Food and Drug Administration (FDA) for its new product RINVOQ for the treatment of moderate to severe atopic dermatitis in adults and children 12 years of age and older. Also, with the increasing disposable income and rising healthcare spending, the adoption & demand for Atopic Dermatitis Treatment is likely to increase the market growth during the forecast period. However, high cost of Atopic Dermatitis Treatment and lack of reimbursement policies impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the Global Atopic Dermatitis Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share owing to increasing prevalence of skin disorders and presence of leading market players in the region. Whereas, Asia-Pacific is anticipated to exhibit highest growth rate over the forecast period 2021-2027. Factors such as growing healthcare infrastructure and increasing prevalence of skin diseases among elder population in the region would create lucrative growth prospects for the Atopic Dermatitis Treatment market across Asia-Pacific region.

Major market player included in this report are:

Sanofi SA Ltd.

Galderma SA Pvt Ltd.

Allergan Plc.

Novartis AG Ltd.

Bristol-Myers Squibb Ltd.

Bayer AG Ltd.

Meda Pharmaceuticals Pvt Ltd.

Astellas Pharma Inc.

Anacor Pharmaceutical Inc.

Regeneron Pharmaceuticals, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Corticosteroids

Calcineurin Inhibitors

Immunosuppressants

Biologic Therapy

PDE-4 Inhibitor

Antibiotics

Antihistamines

Emollients

By Indication:

Topical

Oral

Injectable

By End Use Industries:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Drug Stores

Mail Order Pharmacies

Dermatology Clinics

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019,2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Atopic Dermatitis Treatment Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)

1.2.1. Atopic Dermatitis Treatment Market, by Region, 2020-2028 (USD Billion)

1.2.2. Atopic Dermatitis Treatment Market, by Product, 2020-2028 (USD Billion)

1.2.3. Atopic Dermatitis Treatment Market, by Indication, 2020-2028 (USD Billion)

1.2.4. Atopic Dermatitis Treatment Market, by End Use Industries, 2020-2028 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Atopic Dermatitis Treatment Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Atopic Dermatitis Treatment Market Dynamics

3.1. Atopic Dermatitis Treatment Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Growing prevalence of dermatological skin disorders.

3.1.1.2. Rising Research & Development activities in healthcare industry.

3.1.2. Market Challenges

3.1.2.1. high treatment cost.

3.1.2.2. Lack of reimbursement policies.

3.1.3. Market Opportunities

3.1.3.1. increasing spending on healthcare.

3.1.3.2. Rising disposable income.

Chapter 4. Global Atopic Dermatitis Treatment Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Atopic Dermatitis Treatment Market, by Product

6.1. Market Snapshot

6.2. Global Atopic Dermatitis Treatment Market by Product, Performance - Potential Analysis

6.3. Global Atopic Dermatitis Treatment Market Estimates & Forecasts by Product 2018-2028 (USD Billion)

6.4. Atopic Dermatitis Treatment Market, Sub Segment Analysis

6.4.1. Corticosteroids

6.4.2. Calcineurin Inhibitors

6.4.3. Immunosuppressants

6.4.4. Biologic Therapy

6.4.5. PDE-4 Inhibitor

6.4.6. Antibiotics

6.4.7. Antihistamines

6.4.8. Emollients

Chapter 7. Global Atopic Dermatitis Treatment Market, by Indication

7.1. Market Snapshot

7.2. Global Atopic Dermatitis Treatment Market by Indication, Performance - Potential Analysis

7.3. Global Atopic Dermatitis Treatment Market Estimates & Forecasts by Indication 2018-2028 (USD Billion)

7.4. Atopic Dermatitis Treatment Market, Sub Segment Analysis

7.4.1. Topical

7.4.2. Oral

7.4.3. Injectable

Chapter 8. Global Atopic Dermatitis Treatment Market, by End Use Industries

8.1. Market Snapshot

8.2. Global Atopic Dermatitis Treatment Market by End Use Industries, Performance - Potential Analysis

8.3. Global Atopic Dermatitis Treatment Market Estimates & Forecasts by End Use Industries 2018-2028 (USD Billion)

8.4. Atopic Dermatitis Treatment Market, Sub Segment Analysis

8.4.1. Hospital Pharmacies

8.4.2. Retail Pharmacies

8.4.3. Online Pharmacies

8.4.4. Drug Stores

8.4.5. Mail Order Pharmacies

8.4.6. Dermatology Clinics

Chapter 9. Global Atopic Dermatitis Treatment Market, Regional Analysis

9.1. Atopic Dermatitis Treatment Market, Regional Market Snapshot

9.2. North America Atopic Dermatitis Treatment Market

9.2.1. U.S. Atopic Dermatitis Treatment Market

9.2.1.1. Product breakdown estimates & forecasts, 2018-2028

9.2.1.2. Indication breakdown estimates & forecasts, 2018-2028

9.2.1.3. End Use Industries breakdown estimates & forecasts, 2018-2028

9.2.2. Canada Atopic Dermatitis Treatment Market

9.3. Europe Atopic Dermatitis Treatment Market Snapshot

9.3.1. U.K. Atopic Dermatitis Treatment Market

9.3.2. Germany Atopic Dermatitis Treatment Market

9.3.3. France Atopic Dermatitis Treatment Market

9.3.4. Spain Atopic Dermatitis Treatment Market

9.3.5. Italy Atopic Dermatitis Treatment Market

9.3.6. Rest of Europe Atopic Dermatitis Treatment Market

9.4. Asia-Pacific Atopic Dermatitis Treatment Market Snapshot

9.4.1. China Atopic Dermatitis Treatment Market

9.4.2. India Atopic Dermatitis Treatment Market

9.4.3. Japan Atopic Dermatitis Treatment Market

9.4.4. Australia Atopic Dermatitis Treatment Market

9.4.5. South Korea Atopic Dermatitis Treatment Market

9.4.6. Rest of Asia Pacific Atopic Dermatitis Treatment Market

9.5. Latin America Atopic Dermatitis Treatment Market Snapshot

9.5.1. Brazil Atopic Dermatitis Treatment Market

9.5.2. Mexico Atopic Dermatitis Treatment Market

9.6. Rest of The World Atopic Dermatitis Treatment Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. Sanofi SA Ltd.

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Galderma SA Pvt Ltd.

10.2.3. Allergan Plc.

10.2.4. Novartis AG Ltd.

10.2.5. Bristol-Myers Squibb Ltd.

10.2.6. Bayer AG Ltd.

10.2.7. Meda Pharmaceuticals Pvt Ltd.

10.2.8. Astellas Pharma Inc.

10.2.9. Anacor Pharmaceutical Inc.

10.2.10. Regeneron Pharmaceuticals, Inc

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Atopic Dermatitis Treatment Market, report scope

TABLE 2. Global Atopic Dermatitis Treatment Market estimates & forecasts by Region 2018-2028 (USD Billion)

TABLE 3. Global Atopic Dermatitis Treatment Market estimates & forecasts by Product 2018-2028 (USD Billion)

TABLE 4. Global Atopic Dermatitis Treatment Market estimates & forecasts by Indication 2018-2028 (USD Billion)

TABLE 5. Global Atopic Dermatitis Treatment Market estimates & forecasts by End Use Industries 2018-2028 (USD Billion)

TABLE 6. Global Atopic Dermatitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 7. Global Atopic Dermatitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 8. Global Atopic Dermatitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 9. Global Atopic Dermatitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 10. Global Atopic Dermatitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 11. Global Atopic Dermatitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 12. Global Atopic Dermatitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 13. Global Atopic Dermatitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 14. Global Atopic Dermatitis Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 15. Global Atopic Dermatitis Treatment Market by region, estimates & forecasts, 2018-2028 (USD Billion)

TABLE 16. U.S. Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 17. U.S. Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 18. U.S. Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 19. Canada Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 20. Canada Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 21. Canada Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 22. UK Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 23. UK Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 24. UK Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 25. Germany Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 26. Germany Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 27. Germany Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 28. RoE Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 29. RoE Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 30. RoE Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 31. China Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 32. China Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 33. China Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 34. India Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 35. India Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 36. India Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 37. Japan Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 38. Japan Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 39. Japan Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 40. RoAPAC Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 41. RoAPAC Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 42. RoAPAC Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 43. Brazil Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 44. Brazil Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 45. Brazil Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 46. Mexico Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 47. Mexico Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 48. Mexico Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 49. RoLA Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 50. RoLA Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 51. RoLA Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 52. Row Atopic Dermatitis Treatment Market estimates & forecasts, 2018-2028 (USD Billion)

TABLE 53. Row Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 54. Row Atopic Dermatitis Treatment Market estimates & forecasts by segment 2018-2028 (USD Billion)

TABLE 55. List of secondary sources, used in the study of Global Atopic Dermatitis Treatment Market

TABLE 56. List of primary sources, used in the study of Global Atopic Dermatitis Treatment Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
View Details
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370
View Details
Global Orphan Drugs Market by Disease Type (Oncologic Diseases, Metabolic Diseases, Hematologic and Immunologic Diseases, Infectious Diseases, Neurologic Diseases and Other Rare Diseases), Indication (Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Cystic Fibrosis, Glioma, Pancreatic Cancer, Ovarian Cancer, Multiple Myeloma, Duchenne Muscular Dystrophy, Graft vs Host Disease, Renal Cell Carcinoma and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022

The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...

  • Publish Date: April 24, 2017
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research